We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

161 hedge funds and large institutions have $695M invested in Meridian Bioscience Inc in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 58 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 161 → 161 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

7% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 58

15% less capital invested

Capital invested by funds: $815M → $695M (-$120M)

78% less call options, than puts

Call options by funds: $522K | Put options by funds: $2.32M

Holders
161
Holders Change
–
Holders Change %
0%
% of All Funds
4.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
54
Reduced
58
Closed
16
Calls
$522K
Puts
$2.32M
Net Calls
-$1.8M
Net Calls Change
-$654K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.6M
2
PP
Prudential plc
United Kingdom
+$3.82M
3
Millennium Management
Millennium Management
New York
+$3.77M
4
RA
Royce & Associates
New York
+$3.5M
5
CIC
Crawford Investment Counsel
Georgia
+$2.44M

Top Sellers

Rank Fund Capital Flow
1
BTW
Boston Trust Walden
Massachusetts
-$25M
2
CCA
Conestoga Capital Advisors
Pennsylvania
-$15.2M
3
PIM
Perkins Investment Management
Illinois
-$13.8M
4
BA
Broadview Advisors
Wisconsin
-$13.1M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$11.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$4.3M +$848K +43,142 +22%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$4.12M +$21.4K +1,087 +0.5%
RA
28
Royce & Associates
New York
$3.43M +$3.5M +177,900 +1,105%
Ameriprise
29
Ameriprise
Minnesota
$3.23M -$1.4M -71,371 -28%
BA
30
Broadview Advisors
Wisconsin
$2.98M -$13.1M -665,875 -80%
MAA
31
Managed Account Advisors
New Jersey
$2.96M -$41K -2,087 -1%
TCIM
32
TIAA CREF Investment Management
New York
$2.86M – – –
New York State Teachers Retirement System (NYSTRS)
33
New York State Teachers Retirement System (NYSTRS)
New York
$2.6M – – –
Wells Fargo
34
Wells Fargo
California
$2.6M +$242K +12,309 +9%
Citadel Advisors
35
Citadel Advisors
Florida
$2.52M +$1.15M +58,455 +70%
GF
36
Gabelli Funds
New York
$2.48M +$98.2K +5,000 +4%
GI
37
GAMCO Investors
Connecticut
$2.48M +$196K +10,000 +8%
Charles Schwab
38
Charles Schwab
California
$2.44M -$98.9K -5,034 -4%
BIM
39
BlackRock Investment Management
Delaware
$2.42M -$2.16K -110 -0.1%
TA
40
Teton Advisors
New York
$2.37M +$177K +9,000 +7%
ACM
41
American Capital Management
New York
$2.34M – – –
MC
42
Menta Capital
California
$2.25M +$1.9M +96,622 +318%
Invesco
43
Invesco
Georgia
$2.1M -$24.3K -1,235 -1%
Goldman Sachs
44
Goldman Sachs
New York
$1.98M +$174K +8,850 +9%
CIS
45
Connors Investor Services
Pennsylvania
$1.93M +$6.93K +353 +0.3%
ZAM
46
Zevin Asset Management
Massachusetts
$1.81M +$2.01M +102,405 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.81M +$122K +6,210 +6%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$1.76M – – –
KAM
49
Keeley Asset Management
Illinois
$1.73M -$90.4K -4,600 -4%
NFA
50
Nationwide Fund Advisors
Ohio
$1.73M -$488K -24,844 -20%
1
2
3 4 5

VIVO Hedge Fund Activity: Q3 2014 in Review

161 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2014, worth a combined $695M — down 15% from $815M a quarter earlier.

Fund positioning in VIVO was balanced in Q3 2014: 16 funds opened new positions, 16 closed out, 54 added to existing stakes and 58 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $63.6M. The largest seller was Boston Trust Walden, exiting entirely with an estimated $25M sold.

  • 161 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $695M of Meridian Bioscience Inc stock for Q3 2014, down 15% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q3 2014 and 16 closed out, a net change of 0 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2014 was Fidelity Investments, an estimated $63.6M added.
  • The largest Meridian Bioscience Inc seller in Q3 2014 was Boston Trust Walden, an estimated $25M sold.

Based on aggregated 13F filings for Q3 2014.